syntapharma.com

Synta Pharmaceuticals Corp

Trials by Tumor Type. Non-Small Cell Lung Cancer. Malignant Peripheral Nerve Sheath Tumors. Small Cell Lung Cancer. Corporate Presentation August 2015. STA-12-8666 Poster Presentation (AACR Annual Meeting 2015). 2015 Synta Pharmaceuticals About Us. The use of this site is governed by the Terms of Use. By using this site you acknowledge that you have read the Terms of Use and the disclaimers and caveats contained in this site, and that you accept and agree to be bound by the terms thereof.

http://www.syntapharma.com/

OVERVIEW OF syntapharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR SYNTAPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 5 reviews

5 star

1

4 star

4

3 star

0

2 star

0

1 star

0

Hey there! Start your review of syntapharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.3 seconds

CONTACTS AT SYNTAPHARMA.COM

Safi Bahcall

Safi Bahcall

45 Ha●●●●●l Ave

Lex●●●ton , MA, 02421

US

1.78●●●●8200

sa●●@syntapharma.com

View this contact

Michael Ahlfont

Michael Ahlfont

45 Ha●●●●●l Ave

Lex●●●ton , ma, 02421

US

1.61●●●●8200

ma●●●●●●@gmail.com

View this contact

Synta Pharmaceuticals

Michael Ahlfont

45 Ha●●●●●l Ave

Lex●●●ton , MA, 02421

US

1.61●●●●8200

ma●●●●●●@syntapharma.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2001 July 01
UPDATED: 2013 October 18
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

23

YEARS
10

MONTHS
8

DAYS

NAME SERVERS

1: ns0.dnsmadeeasy.com
2: ns1.dnsmadeeasy.com
3: ns2.dnsmadeeasy.com
4: ns3.dnsmadeeasy.com
5: ns4.dnsmadeeasy.com

REGISTRAR

REGISTER.COM, INC.

WHOIS : whois.register.com

REFERRED : http://www.register.com

CONTENT

PAGES IN
THIS WEBSITE

9

SSL

EXTERNAL LINKS

104

SITE IP

209.237.151.15

LOAD TIME

0.266 sec

SCORE

6.2

PAGE TITLE

Synta Pharmaceuticals Corp | syntapharma.com Reviews

<META> DESCRIPTION

Trials by Tumor Type. Non-Small Cell Lung Cancer. Malignant Peripheral Nerve Sheath Tumors. Small Cell Lung Cancer. Corporate Presentation August 2015. STA-12-8666 Poster Presentation (AACR Annual Meeting 2015). 2015 Synta Pharmaceuticals About Us. The use of this site is governed by the Terms of Use. By using this site you acknowledge that you have read the Terms of Use and the disclaimers and caveats contained in this site, and that you accept and agree to be bound by the terms thereof.

<META> KEYWORDS

1 about us

2 company overview

3 management team

4 board of directors

5 directions

6 pipeline

7 overview

8 ganetespib

9 presentations

10 publications

CONTENT

Page content here

KEYWORDS ON PAGE

about us,company overview,management team,board of directors,directions,pipeline,overview,ganetespib,presentations,publications,elesclomol,clinical trials,breast cancer,acute myeloid leukemia,ovarian cancer,colon/rectal cancer,mesothelioma,ocular melanoma

SERVER

Microsoft-IIS/7.0

POWERED BY

PHP/5.2.17,ASP.NET

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Synta Pharmaceuticals Corp | syntapharma.com Reviews

https://syntapharma.com

Trials by Tumor Type. Non-Small Cell Lung Cancer. Malignant Peripheral Nerve Sheath Tumors. Small Cell Lung Cancer. Corporate Presentation August 2015. STA-12-8666 Poster Presentation (AACR Annual Meeting 2015). 2015 Synta Pharmaceuticals About Us. The use of this site is governed by the Terms of Use. By using this site you acknowledge that you have read the Terms of Use and the disclaimers and caveats contained in this site, and that you accept and agree to be bound by the terms thereof.

INTERNAL PAGES

syntapharma.com

1

Synta Pharmaceuticals Corp : Pipeline : Ganetespib Publications

http://www.syntapharma.com/pipeline-ganetespib-publications.php

Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. 2015 June; 3(6): 583-589. Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy. DA Proia and GF Kaufmann. 2015 May 21; [Epub ahead of print]. A Randomized Phase 2 Study of Ganetespib, A Heat Shock Protein 90 Inhibitor, In Combination With Docetaxel in Second-Line Therapy of Advanced Non-Small-Cell Lung Cancer (GALAXY-1). 2015 May 22; 7(2): 876-907. Epub ahead of print]. Heat sho...

2

Synta Pharmaceuticals Corp : Clinical Trials

http://www.syntapharma.com/clinical-trials.php

Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. Synta places a high priority on sharing information and results regarding our ongoing and completed clinical studies with the medical community. We have registered all of our active, company-sponsored clinical trials on the National Institutes of Health Web site www.clinicaltrials.gov. This information is available on this site as well. 2016 Synta Pharmaceuticals About Us.

3

Synta Pharmaceuticals Corp : Clinical Trials : Ovarian Cancer

http://www.syntapharma.com/clinical-trials-ovarian-cancer.php

Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. GANNET53 Trial: A randomized trial in metastatic, predominantly p53 mutant, platinum resistant ovarian cancer in combination with paclitaxel. Click here for more information about this trial. Phase 1/2 trial in ovarian cancer in combination with paclitaxel. Click here for more information about this trial. 2016 Synta Pharmaceuticals About Us.

4

Synta Pharmaceuticals Corp : Clinical Trials : Malignant Peripheral Nerve Sheath Tumors

http://www.syntapharma.com/clinical-trials-nerve-sheath-tumors.php

Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. Malignant Peripheral Nerve Sheath Tumors. A Phase 1/2 Trial of Ganetespib in Combination With the mTOR Inhibitor Sirolimus for Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST). Click here for more information about this trial. 2016 Synta Pharmaceuticals About Us.

5

Synta Pharmaceuticals Corp : Pipeline : Ganetespib Presentations

http://www.syntapharma.com/pipeline-sta128666-presentations.php

Trials by Tumor Type. Malignant Peripheral Nerve Sheath Tumors. The 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. May29 - June 2, 2015 - Chicago, IL. Activity of Hsp90 inhibitor drug conjugate (HDC) STA-12-8666 in preclinical models of pediatric sarcoma. 106th Annual Meeting of the American Association for Cancer Research. April 18 - 22, 2015 - Philadelphia, PA. STA-12-8666: a first-in-class HSP90 inhibitor drug conjugate (HDC) designed to selectively deliver chemotherapy to tumors.

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

convergenceforum.com

About - Convergence Forum

http://convergenceforum.com/advisorseast.html

Life Science Leader Conference. News & Media. What opportunities get created as fields converge? What challenges surface as markets, policies, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others), with a high-level audience interested in what’s happening in the rapidly-converging worlds of biotech, pharma, healthcare, medical devices, and the Internet. What Makes It Different. Our programs deliver a rapi...

report.biotoday.com

Biotodayブログ: 古屋圭三さんアーカイブ

http://report.biotoday.com/cat7

2006年04月02日. 続きを読む "バイオインタビュー古屋圭三さん、4回目" ». 投稿者: せいみや日時: 10:45. 2006年03月19日. 金曜日のメルマガでお伝えしましたように、日曜特別号バイオインタビューとして、 Synta. 続きを読む "バイオインタビュー古屋圭三さん、3回目" ». 投稿者: せいみや日時: 08:14. 2006年03月13日. 昨日のメルマガでお伝えしましたように、日曜特別号バイオインタビューとして、 Synta社. 続きを読む "バイオインタビュー古屋圭三さん、2回目" ». 投稿者: せいみや日時: 14:27. 2006年03月06日. 続きを読む "古屋圭三さん第1回目 " ». 投稿者: せいみや日時: 13:18. 2006年02月22日. Synta シンタ社の上級副社長古屋氏のインタビューが遅れます. Synta シンタ社の上級副社長古屋氏のインタビューについて3点お知らせがあります。続きを読む "Synta シンタ社の上級副社長古屋氏のインタビューが遅れます" ». 投稿者: せいみや日時: 22:20.

UPGRADE TO PREMIUM TO VIEW 102 MORE

TOTAL LINKS TO THIS WEBSITE

104

OTHER SITES

syntap.net

InMotion Hosting

Your IP is 67.219.144.170.

syntapa.com

Syntapa Technologies Inc

System for less than $25 per. The Syntapa Information Management System (IMS). Can be deployed on-site or as a cloud based solution! Start realizing the benefits of a robust information. Management system for one low monthly. Our expert resources and easily. Allow you to focus your time. And money towards growing. Your business.not on. AMS solution will help. Manage your member,. Donor, and supporter. At Syntapa Technologies, we are Information Management specialists! What is Information Management?

syntapademo.com

Page Title

Welcome to the Syntapa eIS Demonstration site. The Syntapa eIS solution is an award winning Association Management Software Suite. Our eIS solution was launched in 1997 in direct response to client needs within the regulatory body, professional associations, government agencies, trade unions/associations, insurance, legal and other service industries. Http:/ www.syntapa.com/syntapa-eis/. By logging in as an administrator you will have access to the full capabilities that we have configured into the demon...

syntapaint.ch

syntapaint.ch - This domain may be for sale!

Find the best information and most relevant links on all topics related to syntapaint.ch. This domain may be for sale!

syntapharm.net

Website Disabled

Sorry, the site you requested has been disabled.

syntapharma.com

Synta Pharmaceuticals Corp

Trials by Tumor Type. Non-Small Cell Lung Cancer. Malignant Peripheral Nerve Sheath Tumors. Small Cell Lung Cancer. Corporate Presentation August 2015. STA-12-8666 Poster Presentation (AACR Annual Meeting 2015). 2015 Synta Pharmaceuticals About Us. The use of this site is governed by the Terms of Use. By using this site you acknowledge that you have read the Terms of Use and the disclaimers and caveats contained in this site, and that you accept and agree to be bound by the terms thereof.

syntaps.com

syntaps.com - syntaps Resources and Information.

This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

syntaps.net

syntapsys.bandcamp.com

syntapsys

Never been here before EP. Includes unlimited streaming via the free Bandcamp app, plus high-quality download in MP3, FLAC and more. Never been here before. Released 22 June 2015. Feeds for this album. Experimental electronics since 2008. Never been here before EP. Acting like a bear-EP. Switch to mobile view.

syntaptech.com

SynTap « Empower Connect Enable

Syntap – Connected Customer. July 21, 2015. Syntap – Empowered Customer. July 20, 2015. July 11, 2015. Empowering the in-store shopper with a consistent and connected Omni experience. Omni shoppers spend 50% more than single channel shoppers. Today’s shopper is connected and informed. SynTap allows the retailer to offer a connected experience in a brand centric ecosystem and influence customer buying behavior. Syntap’s ASA clientelling App allows intelligent client advising and mobile check out. More rel...

syntaptic.com

Welcome syntaptic.com - BlueHost.com

Web Hosting - courtesy of www.bluehost.com.